Member Info for BillB

Will the fundraise be announced after the markets close today? Who has the balls to hold this absolute basketcase of a company past 4.30pm today???

He won't be a multi-millionaire for long then!

Not much positive spin STT1 can put on these RNS's. New all time low on the way???

WOW!! Didn't expect that this morning! Could Leon have played a blinder?? ATB

Another piece of fantastic news for BRES! AFC is huge in Africa and a great endorsement for our project. ATB

Another month of increased revenue! Imagine where we'll be with 30, 40, 50+MW in the next months/years? ATB

Certainly is squeaky bum time if the trades are anything to go by. Placing incoming here. Should be up with all the buys today, but ask drops after nearly every buy. Telltale sign of another crushing discounted placement.

Looks like a few people are starting to stock up for what should be the best monthly revenue figures so far! Looking forward to seeing some excellent numbers. ATB

I'm afraid Solvista is right! Including the acquisition revenue for 2025 means HVO are at least £10m down on 2024 revenue. Of course if they get this new large HCT confirmed it's a different matter. ATB, could be a rocky day today.

At the the moment. 3.85 to sell my entire holding though! Hope this means the seller/s have finally finished. ATB

Someone's confident. ATB

Great start to the week!! All the ducks lining up here. And M/CAP of less than £1m?? Not for long.....ATB

Agree wholeheartedly Bunsenburner and Maidit. Bought another 600000 just now. ATB

WOW! Thought figures would have improved, but now in profit for the 1st time ever - A year earlier than expected. Great numbers to read. ATB

Cathel screwed another company. Probably for his own benefit again!! Unlucky all.

The Mail article - Also on Wednesday, genedrive rallied 16 per cent after netting a recommendation from the UK's National Institute for Health and Care Excellence (NICE) for its CYP2C19-ID Kit.

NICE agreed that CYP2C19 should be used to guide clopidogrel use after Ischaemic Stroke or Transient Ischaemic Attack and that the Genedrive CYP2C19-ID test should be used as the test of choice for point-of-care strategies.

Also, thanks for the replies to my projections post yesterday. Appreciated. ATB

Hi All. Bought in this morning on the excellent RNS. Are there any revenue projections for the CYP2C19-ID kit. I see NICE have given it the ok in England and also the SHTG for Scotland. ATB

I am! ATB

And the award for the most bitter poster goes to........................................Gold Investor!! Give it a rest you fool.

Trek, I wouldn't touch this until the situation with funding is sorted! Doesn't look good at the moment ,but may change. 20% down today and still nobody wants to buy! Anybody seen the Vice President of Investor Relations? What a great job that must be! Money for old rope???